Looming Axiron net sales results for Q1 - 2015, page-3

  1. 999 Posts.
    lightbulb Created with Sketch. 25
    I guess it's a wait and see?

    If I was a consumer of the product, it's evident that there are issues in relation to cardiovascular and stroke etc. However there are multiple other issues in relation to blood clots, enlarged breasts, prostate, swelling, breathing etc...

    I think the threats may be taken with a grain of salt. If i'm 60+ and there's a product that can boost my energy, increase muscle mass and libido - then I'm taking it regardless of the sideaffects.

    Look at booze and cigarettes - everyone knows the risks but they still consume in the products.

    IMHO the biggest risk is doctors and Insurance companies. If they curb the amount of prescriptions, it could mean problems for Acrux.
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
1.9¢
Change
0.000(0.00%)
Mkt cap ! $7.747M
Open High Low Value Volume
1.9¢ 1.9¢ 1.9¢ $5.562K 292.7K

Buyers (Bids)

No. Vol. Price($)
4 381825 1.9¢
 

Sellers (Offers)

Price($) Vol. No.
2.0¢ 60000 2
View Market Depth
Last trade - 15.04pm 20/06/2025 (20 minute delay) ?
ACR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.